A new survey of nearly 100 U.S. primary care and other outpatient facilities reveals that while basic screening for heart, kidney and metabolic risks is common, far fewer clinics are using newer, guideline-recommended tools for comprehensive cardiovascular-kidney-metabolic (CKM) syndrome assessment. The findings, presented at the American Heart Association's Scientific Sessions 2026, underscore a critical gap in translating evolving evidence into routine clinical practice.
The research, a baseline assessment of sites participating in the American Heart Association's CKM Health Initiative, found that 75% of clinical sites screened for CKM-related conditions and 73% systematically tested patient populations for CKM risk factors. However, only 28% used the PREVENT equations to estimate cardiovascular disease risk, and merely 22% used CKM syndrome staging. These tools are designed to provide a more integrated approach to managing the interconnected conditions of obesity, Type 2 diabetes, chronic kidney disease and heart disease.
"We found that most of the sites were actively screening patients for CKM risk factors and related conditions. Far fewer were using specifically recommended clinical assessment tools such as CKM syndrome staging and the PREVENT equations," said lead author Chiadi Ndumele, M.D., Ph.D., M.H.S., FAHA, director of the Penn Center for Cardiometabolic Health at the University of Pennsylvania. "However, that isn't entirely surprising. These tools - and even CKM syndrome as a medical condition - embrace relatively new concepts just beginning to be adopted."
The implications are significant. Nearly 90% of U.S. adults have at least one component of CKM syndrome, such as high blood pressure, abnormal cholesterol, high blood glucose, excess weight, reduced kidney function or related heart conditions. The low adoption of comprehensive assessment tools means many patients may not receive the coordinated, preventive care that could slow disease progression. The cardiovascular-kidney-metabolic (CKM) syndrome framework emphasizes that these conditions cluster together, requiring a holistic approach rather than isolated management.
The American Heart Association launched its learning collaborative and quality improvement initiative in 2025 to help clinical sites adopt a CKM-coordinated care model. The baseline survey, conducted between August 2025 and June 2026, included 97 sites, most of which were outpatient facilities, with 44% safety net organizations. The results highlight where implementation efforts should focus, said Ndumele. "The baseline assessments highlight areas most requiring targeted focus of implementation efforts to improve CKM syndrome care," he noted. "These findings could also pave the way for other healthcare sites and hospital systems seeking to improve care for patients with CKM syndrome within their clinical population."
The survey also found that only 22% of sites measured waist circumference as standard practice, despite its importance in assessing CKM risk. The PREVENT equations, based on data from more than 6.5 million diverse U.S. adults, offer improved accuracy for estimating 10-year and 30-year cardiovascular risk. The CKM staging framework, described in a recent guideline-recommended approach, helps identify patients at earlier stages, potentially allowing for timely preventive interventions.
As the initiative continues, ongoing assessments will provide a more comprehensive understanding of barriers and opportunities. The preliminary findings, while not yet peer-reviewed, signal an urgent need to bridge the gap between evidence-based tools and everyday clinical practice to address the growing burden of CKM syndrome. For more information on the initiative, visit the release link.


